[HTML][HTML] Strategies to develop a prophylaxis for the prevention of HPA-1a immunization and fetal and neonatal alloimmune thrombocytopenia
M Kjĉr, C Geisen, ÇA Akkök, A Wikman… - … and Apheresis Science, 2020 - Elsevier
Abstract Anti-HPA-1a-antibodies are the main cause of fetal and neonatal alloimmune
thrombocytopenia (FNAIT) which may result in intracranial hemorrhage (ICH) and death …
thrombocytopenia (FNAIT) which may result in intracranial hemorrhage (ICH) and death …
Maternal IgG anti‐A and anti‐B titres predict outcome in ABO‐incompatibility in the neonate
E Bakkeheim, U Bergerud, AC Schmidt‐Melbye… - Acta …, 2009 - Wiley Online Library
Aim: To evaluate predictors for risk of severe hyperbilirubinaemia and kernicterus in ABO‐
incompatible neonates with emphasize on maternal IgG anti‐A/‐B titres. Methods: Blood …
incompatible neonates with emphasize on maternal IgG anti‐A/‐B titres. Methods: Blood …
Use of different DMSO concentrations for cryopreservation of autologous peripheral blood stem cell grafts does not have any major impact on levels of leukocyte-and …
ÇA Akkök, K Liseth, T Hervig, A Ryningen, Ĝ Bruserud… - Cytotherapy, 2009 - Elsevier
Background aims Infusion of stem cell autografts can be associated with adverse effects.
Necrotic normal leukocytes, cytokines or intracellular mediators released from leukocytes …
Necrotic normal leukocytes, cytokines or intracellular mediators released from leukocytes …
Is there a scientific basis for a recommended standardization of collection and cryopreservation of peripheral blood stem cell grafts?
High-dose chemotherapy followed by autologous stem cell transplantation has been used
extensively during the last two decades in the treatment of hematologic malignancies. The …
extensively during the last two decades in the treatment of hematologic malignancies. The …
Determination of fetal RHD type in plasma of RhD negative pregnant women
K Sĝrensen, J Kjeldsen-Kragh, H Husby… - … journal of clinical and …, 2018 - Taylor & Francis
Alloimmunization against the RhD antigen is the most common cause of hemolytic disease
of the fetus and newborn. Antenatal anti-D prophylaxis in addition to postnatal anti-D …
of the fetus and newborn. Antenatal anti-D prophylaxis in addition to postnatal anti-D …
Pediatric red cell and platelet transfusions
ÇA Akkök, J Seghatchian - Transfusion and Apheresis Science, 2018 - Elsevier
The aim of pediatric transfusions should be based on the concept of avoiding unnecessary
transfusions without jeopardizing the patient safety and providing correct blood components …
transfusions without jeopardizing the patient safety and providing correct blood components …
[HTML][HTML] Fetal and neonatal alloimmune thrombocytopenia–The Norwegian management model
H Tiller, MT Ahlen, ÇA Akkök, A Husebekk - Transfusion and Apheresis …, 2020 - Elsevier
In Norway, the management strategy for fetal and neonatal alloimmune thrombocytopenia
(FNAIT) has for more than two decades differed from most other countries. The focus of this …
(FNAIT) has for more than two decades differed from most other countries. The focus of this …
The Norwegian experience with nationwide implementation of fetal RHD genotyping and targeted routine antenatal anti‐D prophylaxis
K Sĝrensen, MS Bĉvre, G Tomter… - Transfusion …, 2021 - Wiley Online Library
Objectives To reduce the risk of RhD alloimmunization during the last trimester of
pregnancy, a targeted routine antenatal anti‐D prophylaxis (RAADP) programme was …
pregnancy, a targeted routine antenatal anti‐D prophylaxis (RAADP) programme was …
Biological response modifiers in photochemically pathogen‐reduced versus untreated apheresis platelet concentrates
A Vetlesen, MR Mirlashari, ÇA Akkök, MR Kelher… - …, 2013 - Wiley Online Library
BACKGROUND: Lipids and other biologically active substances accumulate in platelet
concentrates (PCs) during storage. Some of these substances have been suggested to …
concentrates (PCs) during storage. Some of these substances have been suggested to …
Severe hemolytic transfusion reaction due to anti-A1 following allogeneic stem cell transplantation with minor ABO incompatibility
ÇA Akkök, H Haugaa, A Galgerud, L Brinch - Transfusion and Apheresis …, 2013 - Elsevier
Blood components should be compatible both with the recipient and the donor in the ABO
incompatible allogeneic stem cell transplantation setting. A patient with blood type A2 …
incompatible allogeneic stem cell transplantation setting. A patient with blood type A2 …